In addition, mutations in VHL genes did not affect overall survival rates of patients with ccRCC, regardless of whether RBFOX2 mRNA levels were high or low (Fig. EV5E,F). The gene discussed is RBFOX2; the disease is nonpapillary renal cell carcinoma.